Literature DB >> 9498474

Risk of severe malaria among African infants: direct evidence of clinical protection during early infancy.

R W Snow1, B Nahlen, A Palmer, C A Donnelly, S Gupta, K Marsh.   

Abstract

Little empirical evidence from field-based studies exists on the relative magnitude or duration of clinical protection from Plasmodium falciparum malaria in infancy. A prospective study was undertaken to examine the age distribution of hospital admissions in four geographically and demographically well-defined areas with differing intensities of P. falciparum transmission. Where transmission was perennial, significant clinical protection from severe morbidity was observed up to the third month of life; in the seasonal transmission area, disease rates rose after the sixth month of life. Infants exposed to the highest rates of P. falciparum exposure demonstrated significant declines in the risks of severe malaria from 6 months of age. These data provide direct evidence for the very early acquisition of clinical immunity and for the existence of a period of clinical protection, which together may explain why, in these communities, the cumulative risk of malarial disease throughout childhood appears to decline with increasing transmission intensity.

Entities:  

Mesh:

Year:  1998        PMID: 9498474     DOI: 10.1086/517818

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  51 in total

1.  The role of maternal antibodies in the emergence of severe disease as a result of fragmentation.

Authors:  David Fouchet; Stéphane Marchandeau; Nargès Bahi-Jaber; Dominique Pontier
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

2.  Synergistic and antagonistic interactions between bednets and vaccines in the control of malaria.

Authors:  Yael Artzy-Randrup; Andrew P Dobson; Mercedes Pascual
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

3.  Mastering malaria: what helps and what hurts.

Authors:  Sunetra Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-10       Impact factor: 11.205

4.  The epidemiology of clinical malaria among African children.

Authors:  R W Snow; K Marsh
Journal:  Bull Inst Pasteur       Date:  1998-03

5.  Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants.

Authors:  Anna Dow; Dumbani Kayira; Michael Hudgens; Annelies Van Rie; Caroline C King; Sascha Ellington; Athena Kourtis; Abigail Norris Turner; Steven Meshnick; Zebrone Kacheche; Denise J Jamieson; Charles Chasela; Charles van der Horst
Journal:  Pediatr Infect Dis J       Date:  2012-08       Impact factor: 2.129

6.  Mother-Newborn Pairs in Malawi Have Similar Antibody Repertoires to Diverse Malaria Antigens.

Authors:  Sarah Boudová; Jenny A Walldorf; Jason A Bailey; Titus Divala; Randy Mungwira; Patricia Mawindo; Jozelyn Pablo; Algis Jasinskas; Rie Nakajima; Amed Ouattara; Matthew Adams; Philip L Felgner; Christopher V Plowe; Mark A Travassos; Miriam K Laufer
Journal:  Clin Vaccine Immunol       Date:  2017-10-05

7.  Acquired immunity and postnatal clinical protection in childhood cerebral malaria.

Authors:  S Gupta; R W Snow; C Donnelly; C Newbold
Journal:  Proc Biol Sci       Date:  1999-01-07       Impact factor: 5.349

8.  Health outcomes of HIV-exposed uninfected African infants.

Authors:  Athena P Kourtis; Jeffrey Wiener; Dumbani Kayira; Charles Chasela; Sascha R Ellington; Lisa Hyde; Mina Hosseinipour; Charles van der Horst; Denise J Jamieson
Journal:  AIDS       Date:  2013-03-13       Impact factor: 4.177

9.  Costs of early detection systems for epidemic malaria in highland areas of Kenya and Uganda.

Authors:  Dirk H Mueller; Tarekegn A Abeku; Michael Okia; Beth Rapuoda; Jonathan Cox
Journal:  Malar J       Date:  2009-01-16       Impact factor: 2.979

10.  Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort.

Authors:  N O Duah; D J C Miles; H C Whittle; D J Conway
Journal:  Parasite Immunol       Date:  2010-02       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.